	Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence. Eur Radiol Antonissen N, Schalekamp S, Hahn HK, van Leeuwen KG, Jacobs C. PMID: 42098370 [PubMed - as supplied by publisher]
	Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study. Cancer Treat Res Commun Paappanen V, Jukkola A, Klaavuniemi T, Sailas L, Ahvonen J, Kuitunen H, Selander T, Tengström M, Kärkkäinen M, Kuittinen O, Tiainen S. PMID: 42096838 [PubMed - as supplied by publisher]
	Phase II study of ramucirumab plus erlotinib for treatment-naÃ¯ve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion). Lung Cancer Kaneda H, Tachihara M, Toi Y, Kuyama S, Ichihara E, Fujisaka Y, Azuma K, Kurata T, Kubo A, Tanaka H, Yamada T, Yokoyama T, Kato T, Yamamoto K, Katakami N, Kawai R, Yoshida H, Shintani A, Sawa K, Kawaguchi T. PMID: 42096800 [PubMed - as supplied by publisher]
	[Sinonasal ameloblastoma: Clinical case presentation and literature review]. Rev Med Inst Mex Seguro Soc Martínez-Fernández FJ, Juárez-Aguilar FG. PMID: 42096278 [PubMed - indexed for MEDLINE]
	[Early preeclampsia associated with hydatidiform mole and pulmonary metastasis: A case report]. Rev Med Inst Mex Seguro Soc Rivera-Hernández DA, Montes-Sevilla LD, Murcia-Acero DX, Castillo Medina AL. PMID: 42096254 [PubMed - indexed for MEDLINE]
	LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli health maintenance organization (HMO). Expert Rev Anticancer Ther Moser SS, Zer A, Hejazi A, Passwell N, Hoshen M, Virani A, Sharmokh S, Daaboul N, Gazit S, Bar J. PMID: 42096187 [PubMed - as supplied by publisher]
	Genetic influence of PPAR-Î³ rs1801282 and MTRR rs162036 variants on non-small cell lung cancer risk in Egyptians. Discov Oncol Metwally YF, Zahran RF, El Sadda RR, Refaat S, Elsaid AM. PMID: 42096170 [PubMed]
	Imaging and AI in tertiary prevention of lung cancer: Narrative review and clinical perspectives. Multidiscip Respir Med Molfini Curci C, Morabito A, Pagliaro R, Perrotta F, Ottaiano A, Santone A, D'Agnano V, Mormile R, Gallipoli D'Errico A, Bianco A, Picone C. PMID: 42095808 [PubMed]
	GLUT1 rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control Study. Hum Mutat Li Z, Wang D, Chen J, Wu D, Tang S, Huang J, Deng Y, Wang X, Qiu F, Yang L, Lu J. PMID: 42094236 [PubMed - indexed for MEDLINE]
	Epigenetic inflammation signatures and lung cancer risk among never-smoking women: a nested case-control study. medRxiv Rahman ML, Gargapati A, Hurwitz LM, Hu W, Keil AP, Breeze CE, Chaturvedi A, Shi J, Cai Q, Yang G, Long J, Gao YT, Christiani DC, Rothman N, Zheng W, Shu XO, Wong JYY, Lan Q. PMID: 42094136 [PubMed]
	Orchestration of the tumor microenvironment by citrus flavonoids: from preclinical mechanisms to translational therapeutic. Front Immunol Ma S, Wang X, Li M, Wang W, Ren Y, Shen Y, Yang K, Zhang Z, Feng Z, Tang S. PMID: 42094009 [PubMed - indexed for MEDLINE]
	Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms. Front Immunol He L, Sun Y, Ma B, Lang G, Wen J, Blumenschein GR Jr, Ma H. PMID: 42093990 [PubMed - indexed for MEDLINE]
	The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects. Respir Res Kong Q, Zhang L, Gong S, Wu Y, Wang J. PMID: 42092925 [PubMed - as supplied by publisher]
	Relationship between the advanced lung cancer inflammation index (ALI) and all-cause and cause-specific mortality among patients with chronic obstructive pulmonary disease (COPD): a population-based study. BMC Pulm Med Luo Z, Chen P, Chen L, Ma H, Cao C. PMID: 42092873 [PubMed - as supplied by publisher]
	Association of Coronary Calcification or Vascular Inflammation and Cardiovascular Events and Prognosis in Non-small Cell Lung Cancer: A Retrospective Study. Respir Med Hayashi M, Fujimoto K, Endo J, Matsumoto-Miyazaki J, Kanamori H, Matsuo M, Okura H. PMID: 42092596 [PubMed - as supplied by publisher]
	Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study. Sci Rep Masuda T, Watanabe S, Suzuki R, Yanai K, Yamazaki R, Ando Y, Wakabayashi T, Tanaka S, Shono K, Yanagimura N, Sato M, Tanaka T, Nozaki K, Saida Y, Shima K, Kimura Y, Aoki N, Ohshima Y, Koya T, Sakai K, Nishio K, Yamazaki M, Ishikawa H, Kikuchi T. PMID: 42092113 [PubMed - as supplied by publisher]
	Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming. Signal Transduct Target Ther Zhou L, Liu Y, Xing Z, Wu Y, Yang X, Chen S, Kang K, Wang M, Zhou Z, Huang M, Gong Y, Zhou L, Zhou X, Li J, Yao Z, Zheng Q, Kong FS, Niedermann G, Luo R, Lu Y, Xue J. PMID: 42091852 [PubMed - indexed for MEDLINE]
	The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges. Discov Oncol Song C, Lu DS, Zhao CY, Xu ZY, Peng HJ, Li XL, Zeng HY, Li JH, Guo JJ, Yang N. PMID: 42091781 [PubMed - as supplied by publisher]
	Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy. Intern Med Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y. PMID: 42091458 [PubMed - as supplied by publisher]
	Molecular Pathology of Lung Cancer. Surg Pathol Clin Lingard A, Dacic S. PMID: 42091274 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 158464

Page 1 of 7924



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy